Shanghai Henlius Biotech, Inc.'s (HKG:2696) price-to-sales (or "P/S") ratio of 1.4x might make it look like a strong buy right now compared to the Biotechs industry in Hong Kong, where around half of ...
Source LinkShanghai Henlius Biotech, Inc.'s (HKG:2696) price-to-sales (or "P/S") ratio of 1.4x might make it look like a strong buy right now compared to the Biotechs industry in Hong Kong, where around half of ...
Source Link
Comments